Arlington Trust »

AstraZeneca shares owned by Arlington Trust

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Arlington Trust from 13F filings

Historical chart of Arlington Trust investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Arlington Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Arlington Trust

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 422 67.75
2023-12-31 $37k 543 67.35

More positions owned by Arlington Trust

Vanguard High Dividend Yield ETF (VYM)
Vanguard Europe Pacific ETF (VEA)
Vanguard Dividend Appreciation ETF (VIG)
Vanguard Int High Dvd Yld In exchange traded funds (VYMI)
Microsoft Corporation (MSFT)
Schwab Strategic Tr us lrg cap etf (SCHX)
Vanguard Total Stock Market ETF (VTI)
Apple (AAPL)
Berkshire Hathaway (BRK.B)
iShares S&P 500 Value Index (IVE)
Proshares Tr russ 2000 divd (SMDV)
Spdr S&p 500 Etf (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)

View all positions for Arlington Trust

Top funds holding AstraZeneca

T. Rowe Price Associates
Wellington Management Company
PRIMECAP Management Company
Jennison Associates
Sanders Capital
Goldman Sachs Group
Bank of America Corporation
Franklin Resources
Fisher Investments
Atlantic Trust
BlackRock
Dimensional Fund Advisors
Holocene Advisors
Jpmorgan Chase & Co
ClearBridge Advisors

View all funds holding AstraZeneca